We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $209M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+33.81%
3 Year Est. Return
+83.09%
5 Year Est. Return
+106.57%
10 Year Est. Return
+388.31%
AUM
$148M
AUM Growth
+$20.7M
Cap. Flow
+$8.99M
Cap. Flow %
6.07%
Top 10 Hldgs %
34.61%
Holding
81
New
5
Increased
30
Reduced
18
Closed
2

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$201K
2
ABBV icon
AbbVie
ABBV
+$131K
3
INTC icon
Intel
INTC
+$93.3K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$89.3K
5
NVDA icon
NVIDIA
NVDA
+$88.1K

Sector Composition

Rank Sector Weight
1 Healthcare 21.65%
2 Technology 21.02%
3 Miscellaneous 19.55%
4 Industrials 10.66%
5 Consumer Discretionary 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
51
Colgate-Palmolive
CL
$69.3B
$281K 0.19%
3,295
-54
-2% -$4.22K
AMT icon
52
American Tower
AMT
$82.6B
$264K 0.18%
906
MRSH
53
Marsh
MRSH
$85.9B
$236K 0.16%
1,355
-35
-3% -$5.81K
EW icon
54
Edwards Lifesciences
EW
$49.5B
$214K 0.14%
+1,650
New +$192K
TXN icon
55
Texas Instruments
TXN
$240B
-1,046
Closed -$201K

Similar funds

Nancy E. Dempze's Q4 2021 Portfolio in Review

As of Q4 2021, Nancy E. Dempze held 81 positions worth $148M, up 16% from $127M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Nancy E. Dempze deployed $8.99M of net new capital in Q4 2021, opening 5 new positions and adding to 30 existing holdings. Its largest new stake was Vanguard Dividend Appreciation ETF: 6,548 shares worth $1.13M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was AbbVie, an estimated $131K trimmed.

  • Nancy E. Dempze's largest Q4 2021 buy was Vanguard Dividend Appreciation ETF: 6,548 shares worth $1.13M.
  • Nancy E. Dempze added most to Procter & Gamble in Q4 2021, an estimated $314K increase.
  • Nancy E. Dempze's biggest Q4 2021 reduction was AbbVie, cutting an estimated $131K.
  • Nancy E. Dempze fully exited Texas Instruments in Q4 2021, selling an estimated $201K.
  • Nancy E. Dempze's ten largest holdings make up 35% of its $148M portfolio in Q4 2021.
  • Nancy E. Dempze opened 5 new positions and closed 2 in Q4 2021.
  • Nancy E. Dempze's portfolio value rose 16% quarter-over-quarter to $148M.

Based on Nancy E. Dempze's 13F filing for Q4 2021, filed 8 Feb 2022.